Kawasaki disease - diagnosis and treatment
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution
Evaluation of suspected incomplete Kawasaki disease. (1) In the absence... | Download Scientific Diagram
Clinical Practice Guidelines : Kawasaki disease
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease
Kawasaki Disease (Mucocutaneous Lymph Node Syndrome)
Kawasaki disease: AHA statement and recommendations | Contemporary Pediatrics
2017 AHA Guidelines On Kawasaki Disease – A Link And Excerpts | Tom Wade MD
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis - The Lancet Child & Adolescent Health
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría (English Edition)
PDF) Kawasaki Disease: Pathophysiology, Clinical Manifestations, and Management
Kawasaki disease - diagnosis and treatment
Kawasaki Disease – The Leading Cause of Acquired Heart Disease In Children In The USA | Tom Wade MD
Disease of the Week: Kawasaki Disease - UCSD Guardian
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Kawasaki Disease
UHL PICU, EMCHC & Children's Hospital
It is important to be aware that not all... - Kawasaki Disease Canada | Facebook
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health
Kawasaki disease
Frontiers | Kawasaki Disease | Pediatrics
Atypical Kawasaki Disease in 2-Months Old Infant Presenting with Aseptic Meningitis | Semantic Scholar
Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram
